Cancer patients' quality of life directly relates to their survivalMay 16, 2008Study to be presented at the American Society of Clinical Oncology annual meeting ROCHESTER, Minn. -- Patients who feel better live longer, say Mayo Clinic researchers, working with the North Central Cancer Treatment Group (NCCTG), in study results released May 15 as part of the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO). Mayo Clinic cancer researcher and the study's lead author, Angelina Tan, says the results show quality of life is an independent factor in survival. "Quality of life appears to affect the survival of cancer patients," says Tan. "If physicians can identify patients who are not doing well, they will be able to intervene and, we hope, improve not only their patients' sense of well-being, but also their length of life." The researchers compared overall survival with responses from 3,704 patients to one question -- "On a scale of 0 to 10, how would you rate your quality of life?" Patients had a variety of cancer types, and the question was asked during their participation in one of 24 different NCCTG clinical trials. The unifying factor for the patients was that all had late-stage disease. All results were converted to a 100-point scale. The team found that baseline quality of life was a strong predictor of survival. They found a distinct difference when dividing patients by the median score of 83 (6.1 months increased survival time for those with scores greater than or equal to 83). The investigators also divided the group into those with scores of more than 50 and 50 or less, defining those in the 50 or less category as having clinically deficient quality of life. In this analysis, the results were even more striking, with increased survival of 7.5 months for the non-clinically deficient patients. The investigators determined that these numbers were independent of performance status (a traditionally used survival prediction method evaluating a patient's ambulatory status). This study is one of several similar quality of life studies that are being presented by Mayo Clinic researchers at the ASCO annual meeting. "Quality of life research is a priority at Mayo," says Jeff Sloan, Ph.D., a cancer researcher at Mayo and the study's primary investigator. "While doctors know that a patient's quality of life is important, these studies show that measuring it is necessary and can predict how patients will do." Dr. Sloan, Tan and their colleagues at Mayo Clinic and NCCTG hope current and future research will identify both how and when clinicians can best support their patients' feelings of well-being. For example, if the quality of life deficit was identified to be related to patient fatigue and emotional distress, interventions (pharmaceutical, psychosocial, etc.) could be offered to improve patient well-being. "If quality of life deficits can be identified routinely in clinical practice, it will help patients," says Tan. "Physicians can address the issues leading to a decrease in quality of life, and ideally these interventions will extend survival." Other researchers included Paul Novotny; Judith Kaur, M.D.; and Jan Buckner, M.D., all from Mayo Clinic. NCCTG researchers included Paul Schaefer, M.D., Toledo Community Hospital Oncology Program, Toledo, Ohio; Philip Stella, M.D., St. Joseph Mercy Health System, Ann Arbor, Mich.; and John Kuebler, M.D., Columbus Community Clinical Oncology Program, Columbus, Ohio. Related quality of life studies being presented at ASCO include: Baseline quality of life is a strong prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer, Schild et al. A quality-of-life assessment of patients participating in phase I clinical trials confirms a decrease during treatment, Atherton et al. Baseline quality of life is a strong and performance status-independent prognostic factor for overall survival in patients with metastatic colorectal cancer, Turja et al. Tumor burden is not related to quality of life in patients with metastatic colorectal cancer, Sloan et al. Mayo Clinic |
|||||||||||||||||||||
| Related Quality Of Life Current Events and Quality Of Life News Articles Research reveals exactly how coughing is triggered by environmental irritants Scientists have revealed how environmental irritants such as air pollution and cigarette smoke cause people to cough, in research published today in the American Journal of Respiratory and Critical Care Medicine. Burnout and mental distress strongly related to errors by US surgeons Major medical errors self-reported by American surgeons are strongly related to both burnout and depression. Those findings appear today in the online edition of Annals of Surgery. The Mayo Clinic-led study included collaborators from Johns Hopkins and the American College of Surgeons. Building the smart home wirelessly Like the paperless office, the smart home has been a long time coming, but a report published in the International Journal of Internet Protocol Technology, suggests that radio tags coupled with mobile communications devices could soon provide seamless multimedia services to the home. Engineer designs micro-endoscope to seek out early signs of cancer Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection. Drug for erectile dysfunction improves heart function in young heart-disease patients Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia. Residential design for persons with neurological disability IOS Press announces the November 2009 publication of a special issue of NeuroRehabilitation: An International Journal devoted to residential design for persons with neurodisability. Full recovery now possible for an 'untreatable' mental illness Patients coping with the chaos and misery of Borderline Personality Disorder now have reason for strong confidence in making major life changes through a new treatment, Schema Therapy. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). NIST demonstrates 'universal' programmable quantum processor Physicists at the National Institute of Standards and Technology (NIST) have demonstrated the first "universal" programmable quantum information processor able to run any program allowed by quantum mechanics-the rules governing the submicroscopic world-using two quantum bits (qubits) of information. Elevated biomarkers lead to diminished quality of life in heart attack patients post-discharge Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. More Quality Of Life Current Events and Quality Of Life News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||